The Latest Breaking News from FDA

Trader Joe's had six recalls in five weeks, as Skippy and Hillshire Farms both pulled products. What's going on?

Government advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work

Novavax stock crumbled Monday after the Food and Drug Administration signed off on updated Covid boosters from rivals Pfizer and Moderna.

Health officials say that the Pfizer and Moderna shots likely to be available later this week

U.S. regulators have approved updated COVID-19 vaccines from Pfizer and Moderna, shots aimed at revving up protection this fall and winter

Vaccines for a fall immunization drive against COVID-19 just got the green light from the Food and Drug Administration. The agency says the vaccines can protect people, as hospitalizations tick up.

The growing adoption of advanced technologies by biopharmaceutical companies and the growing demand for personalized medicines are expected to boost the biotech industry. Therefore, it could be wise to buy fundamentally strong biotech stocks MacroGenics (MGNX), Acorda Therapeutics (ACOR), and Shionogi & Co. (SGIOY), which are currently trading under $20.…

Updated COVID-19 shots will be part of a trio of fall vaccines that doctors hope will help avoid another “tripledemic.”

The FDA approved reformulated COVID-19 vaccines from Pfizer and Moderna, but deferred an expected authorization for Novavax’s vaccine.